This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
Relating to radiation protection requirements for radiation-producing machines and radioactive materials.
Submitted by the Department of Health Services.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to scheduling Brorphine.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to sales and use tax provisions.
Submitted by the Department of Revenue.
Report received from Agency, January 3, 2023.
Referred to the committee on Universities and Revenue, January 13, 2023.
Relating to licensure and professional conduct.
Submitted by the Podiatry Affiliated Credentialing Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Licensing, Constitution and Federalism, January 13, 2023.
Relating to service fund for people who are deaf, deafblind or hard of hearing.
Submitted by the Department of Health Services.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to use of the Nationwide Multistate Licensing System and Registry by applicants for, and holders of, licenses under s. 138.14 (payday lenders), ch. 217 (sellers of checks), ch. 218, subch. I (sales finance companies), and s. 218.02 (adjustment service companies) of the Wisconsin Statutes.
Submitted by the Department of Financial Institutions.
Report received from Agency, January 3, 2023.
Referred to the committee on Financial Institutions and Sporting Heritage, January 13, 2023.
Relating to the safety, maintenance, and operation of public pools and water attractions.
Submitted by the Department of Agriculture, Trade and Consumer Protection.
Report received from Agency, January 3, 2023.
Referred to the committee on Government Operations, Elections and Consumer Protection, January 13, 2023.
Relating to plant inspection and pest control.
Submitted by the Department of Agriculture, Trade and Consumer Protection.
Report received from Agency, January 3, 2023.
Referred to the committee on Agriculture and Tourism, January 13, 2023.
Relating to care fund income.
Submitted by the Cemetery Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Financial Institutions and Sporting Heritage, January 13, 2023.
Relating to long-term care services and Medical Assistance fair hearing process.
Submitted by the Department of Health Services.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to licensure requirements.
Submitted by the Occupational Therapists Affiliated Credentialing Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Licensing, Constitution and Federalism, January 13, 2023.
Relating to continuing education.
Submitted by the Occupational Therapists Affiliated Credentialing Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Licensing, Constitution and Federalism, January 13, 2023.
Relating to scheduling Serdexmethylphenidate.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to scheduling ten (10) fentanyl related substances.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to scheduling Alfaxalone.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to Excluding 6-beta-Naltrexol.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to scheduling Fospropofol.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Referred to the committee on Health, January 13, 2023.
Relating to scheduling Embutramide.
Submitted by the Controlled Substances Board.
Report received from Agency, January 3, 2023.
Loading...
Loading...